514
Views
22
CrossRef citations to date
0
Altmetric
Original Article

A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy
Availability of suitable radionuclides

Pages 264-275 | Received 26 Jun 2003, Accepted 10 Feb 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alex N. Eberle & Gabriele Mild. (2009) Receptor-mediated tumor targeting with radiopeptides. Journal of Receptors and Signal Transduction 29:1, pages 1-37.
Read now

Articles from other publishers (21)

Lihui Xuan, Chenjun Bai, Zhao Ju, Jinhua Luo, Hua Guan, Ping-Kun Zhou & Ruixue Huang. (2023) Radiation-targeted immunotherapy: A new perspective in cancer radiotherapy. Cytokine & Growth Factor Reviews.
Crossref
Viktoria Krol, Lucas Mues gennant Koers, Scott McNeil, Cornelia Hoehr & Valery Radchenko. (2023) Cyclotron production of 103Pd using a liquid target. Nuclear Medicine and Biology 118-119, pages 108328.
Crossref
Hamza A. Mezher, Kadhim Al-Attafi, Bashar Alkotbe & Wisam N. Hussein. (2023) Investigation of the Cross-Sections for the Production of Bromine Isotopes Using Proton-Induced Reactions. Ukrainian Journal of Physics 67:11, pages 811.
Crossref
Vladimir M. Tolmachev, Vladimir I. Chernov & Sergey M. Deyev. (2022) Targeted nuclear medicine. Seek and destroy. Russian Chemical Reviews 91:3, pages RCR5034.
Crossref
Aleksandra Rękorajska, Grzegorz Cichowicz, Michal K. Cyranski, Michal Grden, Marek Pekala, Gary J. Blanchard & Pawel Krysinski. (2018) Synthesis and Characterization of Tb-Doped Nanoferrites. ChemNanoMat 4:2, pages 231-242.
Crossref
F. F. Knapp & Ashutosh DashF. F. Knapp & Ashutosh Dash. 2016. Radiopharmaceuticals for Therapy. Radiopharmaceuticals for Therapy 25 35 .
Xiang Hu, Hongguang Liu & Zhen Cheng. 2014. Engineering in Translational Medicine. Engineering in Translational Medicine 317 342 .
Charlotte Lund Denholt, Tina Binderup, Marie-Thérése Stockhausen, Hans Skovgaard Poulsen, Mogens Spang-Thomsen, Paul Robert Hansen, Nic Gillings & Andreas Kjær. (2011) Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer. Nuclear Medicine and Biology 38:4, pages 509-515.
Crossref
Nasir Abbas, Helen Heyerdahl, Øyvind S Bruland, Jørgen Borrebæk, Jahn Nesland & Jostein Dahle. (2011) Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab. EJNMMI Research 1:1, pages 18.
Crossref
Uwe Holzwarth. 2011. Radiation Physics for Nuclear Medicine. Radiation Physics for Nuclear Medicine 71 103 .
J.J. Cuaron, J.A. Hirsch, D.C. Medich, B.S. Rosenstein, C.B. Martel & A.E. Hirsch. (2009) A Proposed Methodology to Select Radioisotopes for Use in Radionuclide Therapy. American Journal of Neuroradiology 30:10, pages 1824-1829.
Crossref
Jostein Dahle, Cecilie Krogh, Katrine B. Melhus, Jørgen Borrebæk, Roy H. Larsen & Yngve Kvinnsland. (2009) In Vitro Cytotoxicity of Low-Dose-Rate Radioimmunotherapy by the Alpha-Emitting Radioimmunoconjugate Thorium-227–DOTA–Rituximab. International Journal of Radiation Oncology*Biology*Physics 75:3, pages 886-895.
Crossref
Sture Lindegren, Sofia Frost, Tom Bäck, Elin Haglund, Jörgen Elgqvist & Holger Jensen. (2008) Direct Procedure for the Production of 211 At-Labeled Antibodies with an ε-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate . Journal of Nuclear Medicine 49:9, pages 1537-1545.
Crossref
Vladimir Tolmachev. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy 145 174 .
Torgny Stigbrand, Jörgen Carlsson & Gregory P. Adams. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy 387 397 .
Øyvind S. Bruland, Dahle Jostein, Dag Rune Olsen & Roy H. Larsen. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy 181 194 .
Roy H. Larsen, Jorgen Borrebaek, Jostein Dahle, Katrine B. Melhus, Cecilie Krogh, Miriam H. Valan & Øyvind S. Bruland. (2007) Preparation of TH 227 -Labeled Radioimmunoconjugates, Assessment of Serum Stability and Antigen Binding Ability . Cancer Biotherapy and Radiopharmaceuticals 22:3, pages 431-437.
Crossref
S. Guhlke, A. M. Verbruggen & S. Vallabhajosula. 2007. Clinical Nuclear Medicine. Clinical Nuclear Medicine 34 76 .
A Alfarano, K Abbas, U Holzwarth, M Bonardi, F Groppi, Z Alfassi, E Menapace & P N Gibson. (2006) Thick target yield measurement of 211 At through the nuclear reaction 209 Bi(α, 2n) . Journal of Physics: Conference Series 41, pages 115-122.
Crossref
Eskender Mume, Anna Orlova, Per-Uno Malmström, Hans Lundqvist, Stefan Sjöberg & Vladimir Tolmachev. (2005) Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET. Nuclear Medicine and Biology 32:6, pages 613-622.
Crossref
David S. Urch & Michael J. Welch. (2005) 27  Radiochemistry and radiopharmaceuticals. Annual Reports Section "A" (Inorganic Chemistry) 101, pages 585.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.